$PRAN Recent Headlines U.S. stocks rise; S&P 5
Post# of 102254
Posted On: 04/23/2014 1:21:23 PM
$PRAN Recent Headlines
U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains 4:47 p.m. March 31, 2014 - Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses 3:30 p.m. March 31, 2014 - Sue Chang
Biotech's shares fall 70% on tests 12:39 p.m. March 31, 2014 - Russ Britt
U.S. stock futures extend gains ahead of Yellen 8:58 a.m. March 31, 2014 - Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial 7:50 a.m. March 31, 2014 - Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails 7:22 a.m. March 31, 2014 - Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 5:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results 4:24 p.m. Feb. 18, 2014 - Russ Britt
Prana's Huntington disease therapy meets endpoints 12:51 p.m. Feb. 18, 2014 - MarketWatch.com
Prana Biotechnology up 19% in premarket 9:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 2:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 3:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 11:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 1:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 11:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 10:20 a.m. March 22, 2011 - Val Brickates Kennedy
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure 4:15 p.m. April 14, 2014 - Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble? 11:16 a.m. April 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries 7:00 a.m. April 4, 2014 - TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Down Today 10:13 a.m. April 1, 2014 - TheStreet.com
Benzinga's Top Downgrades 7:00 a.m. April 1, 2014 - benzinga.com
UPDATE: MLV & Co Downgrades Prana Biotechnology Limited Following PBT2 Miss 6:54 a.m. April 1, 2014 - benzinga.com
Shares of Prana Tumble +71.5% After PBT2 Misses Endpoints 10:49 a.m. March 31, 2014 - benzinga.com
Prana collapses after trial fails 6:57 a.m. March 31, 2014 - Seeking Alpha
Prana Alzheimer's Study Fails 6:54 a.m. March 31, 2014 - TheStreet.com
Prana Biotech Announces Preliminary Reults of Phase 2 IMAGINE trial of PBT2 6:09 a.m. March 31, 2014 - benzinga.com
First Week Of November 22nd Options Trading For Prana Biotechnology (PRAN) 11:21 a.m. March 27, 2014 - TheStreet.com
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors 3:49 p.m. March 20, 2014 - Seeking Alpha
Prana to join Aussie index for top 300 companies 10:00 a.m. March 11, 2014 - Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations 8:38 a.m. March 7, 2014 - Seeking Alpha
Prana Biotech Alzheimer approach supported by study 10:49 a.m. March 6, 2014 - Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? 3:24 p.m. March 4, 2014 - Seeking Alpha
A Busy Calendar of March Biotech Events 1:13 p.m. March 3, 2014 - TheStreet.com
Prana: Right Drug, Wrong Dose 9:38 a.m. March 3, 2014 - Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results 6:45 a.m. March 1, 2014 - Seeking Alpha
First Week Of April 19th Options Trading For Prana Biotechnology (PRAN) 12:08 p.m. Feb. 26, 2014 - TheStreet.com
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. Today - PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited 9:03 a.m. Today - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 10:47 a.m. April 16, 2014 - ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year 2:00 a.m. April 1, 2014 - ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease 7:05 a.m. March 31, 2014 - PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 12:19 p.m. March 28, 2014 - PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective 9:30 a.m. March 4, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 1:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease 7:02 a.m. Feb. 18, 2014 - PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 9:00 a.m. Dec. 20, 2013 - PR Newswire
Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial 10:03 a.m. Dec. 10, 2013 - Marketwire
Prana Completes PBT2 Dosing in IMAGINE Alzheimer's Disease Clinical Trial 10:02 a.m. Dec. 9, 2013 - Marketwire
Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar 9:00 a.m. Nov. 20, 2013 - PR Newswire
Prana's PBT2 Featured as a Top 10 Global Neuroscience Project 10:02 a.m. Nov. 19, 2013 - Marketwire
Prana Provides Update on IMAGINE Trial and Extension Trial for Alzheimer's Disease 10:02 a.m. Nov. 18, 2013 - Marketwire
Prana Responds to Media Segment Under ASX Guidance Note 8 10:01 a.m. Nov. 15, 2013 - Marketwire
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 9:00 a.m. Nov. 4, 2013 - PR Newswire
Prana's PBT2 Reverses Memory Loss in Normal Aging 10:07 a.m. Oct. 30, 2013 - Marketwire
Five Star Equities Issues New Research Reports on DSX, LAKE, PRAN and SWY 9:00 a.m. Sept. 16, 2013 - ACCESSWIRE
U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains 4:47 p.m. March 31, 2014 - Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses 3:30 p.m. March 31, 2014 - Sue Chang
Biotech's shares fall 70% on tests 12:39 p.m. March 31, 2014 - Russ Britt
U.S. stock futures extend gains ahead of Yellen 8:58 a.m. March 31, 2014 - Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial 7:50 a.m. March 31, 2014 - Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails 7:22 a.m. March 31, 2014 - Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 5:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results 4:24 p.m. Feb. 18, 2014 - Russ Britt
Prana's Huntington disease therapy meets endpoints 12:51 p.m. Feb. 18, 2014 - MarketWatch.com
Prana Biotechnology up 19% in premarket 9:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 2:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 3:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 11:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 1:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 11:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 10:20 a.m. March 22, 2011 - Val Brickates Kennedy
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure 4:15 p.m. April 14, 2014 - Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble? 11:16 a.m. April 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries 7:00 a.m. April 4, 2014 - TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Down Today 10:13 a.m. April 1, 2014 - TheStreet.com
Benzinga's Top Downgrades 7:00 a.m. April 1, 2014 - benzinga.com
UPDATE: MLV & Co Downgrades Prana Biotechnology Limited Following PBT2 Miss 6:54 a.m. April 1, 2014 - benzinga.com
Shares of Prana Tumble +71.5% After PBT2 Misses Endpoints 10:49 a.m. March 31, 2014 - benzinga.com
Prana collapses after trial fails 6:57 a.m. March 31, 2014 - Seeking Alpha
Prana Alzheimer's Study Fails 6:54 a.m. March 31, 2014 - TheStreet.com
Prana Biotech Announces Preliminary Reults of Phase 2 IMAGINE trial of PBT2 6:09 a.m. March 31, 2014 - benzinga.com
First Week Of November 22nd Options Trading For Prana Biotechnology (PRAN) 11:21 a.m. March 27, 2014 - TheStreet.com
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors 3:49 p.m. March 20, 2014 - Seeking Alpha
Prana to join Aussie index for top 300 companies 10:00 a.m. March 11, 2014 - Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations 8:38 a.m. March 7, 2014 - Seeking Alpha
Prana Biotech Alzheimer approach supported by study 10:49 a.m. March 6, 2014 - Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? 3:24 p.m. March 4, 2014 - Seeking Alpha
A Busy Calendar of March Biotech Events 1:13 p.m. March 3, 2014 - TheStreet.com
Prana: Right Drug, Wrong Dose 9:38 a.m. March 3, 2014 - Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results 6:45 a.m. March 1, 2014 - Seeking Alpha
First Week Of April 19th Options Trading For Prana Biotechnology (PRAN) 12:08 p.m. Feb. 26, 2014 - TheStreet.com
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. Today - PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited 9:03 a.m. Today - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 10:47 a.m. April 16, 2014 - ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year 2:00 a.m. April 1, 2014 - ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease 7:05 a.m. March 31, 2014 - PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 12:19 p.m. March 28, 2014 - PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective 9:30 a.m. March 4, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 1:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease 7:02 a.m. Feb. 18, 2014 - PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 9:00 a.m. Dec. 20, 2013 - PR Newswire
Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial 10:03 a.m. Dec. 10, 2013 - Marketwire
Prana Completes PBT2 Dosing in IMAGINE Alzheimer's Disease Clinical Trial 10:02 a.m. Dec. 9, 2013 - Marketwire
Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar 9:00 a.m. Nov. 20, 2013 - PR Newswire
Prana's PBT2 Featured as a Top 10 Global Neuroscience Project 10:02 a.m. Nov. 19, 2013 - Marketwire
Prana Provides Update on IMAGINE Trial and Extension Trial for Alzheimer's Disease 10:02 a.m. Nov. 18, 2013 - Marketwire
Prana Responds to Media Segment Under ASX Guidance Note 8 10:01 a.m. Nov. 15, 2013 - Marketwire
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 9:00 a.m. Nov. 4, 2013 - PR Newswire
Prana's PBT2 Reverses Memory Loss in Normal Aging 10:07 a.m. Oct. 30, 2013 - Marketwire
Five Star Equities Issues New Research Reports on DSX, LAKE, PRAN and SWY 9:00 a.m. Sept. 16, 2013 - ACCESSWIRE
(0)
(0)Scroll down for more posts ▼